Clinical trial
Reduction of Plasma Vasopressin Level in Patients With Meniere's Disease
NCT01099046 is registered in ClinicalTrials.gov with Osaka University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Reduction of Plasma Vasopressin Level in Patients With Meniere's Disease
- Lead sponsor
- Osaka University
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- January 31, 2009
- Completion date
- January 31, 2020
- Enrollment
- 200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
meniere's disease, stress